Gene · 57007
Papers3,960
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,960
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploration of prognostic and treatment markers in hepatocellular carcinoma via GPCR-related genes analysis. | Heliyon | 2024 | 38694033 | PubTator, text mining | PubMed |
| Relationship between chemokine/chemokine receptor and glioma prognosis and outcomes: Systematic review and meta-analysis. | Int Immunopharmacol | 2024 | 38631221 | PubTator, text mining | PubMed |
| The Role of CXCL11 and its Receptors in Cancer: Prospective but Challenging Clinical Targets. | Cancer Control | 2024 | 38533911 | PubTator, text mining | PubMed |
| CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. | Sci Signal | 2024 | 38502733 | PubTator, text mining | PubMed |
| Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome. | BMC Genomics | 2024 | 38475709 | PubTator, text mining | PubMed |
| Crosstalk between purinergic receptor P2Y11 and chemokine receptor CXCR7 is regulated by CXCR4 in human macrophages. | Cell Mol Life Sci | 2024 | 38472446 | PubTator, text mining | PubMed |
| TC14012 enhances the anti-fibrosis effects of UC-MSCs on the liver by reducing collagen accumulation and ameliorating inflammation. | Stem Cell Res Ther | 2024 | 38360740 | PubTator, text mining | PubMed |
| Pharmacological Characterization and Radiolabeling of VUF15485, a High-Affinity Small-Molecule Agonist for the Atypical Chemokine Receptor ACKR3. | Mol Pharmacol | 2024 | 38346795 | PubTator, text mining | PubMed |
| CXCL14 as a Key Regulator of Neuronal Development: Insights from Its Receptor and Multi-Omics Analysis. | Int J Mol Sci | 2024 | 38338930 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals the MIF-ACKR3 receptor-ligand interaction between iCAFs and tumor cells in esophageal squamous cell carcinoma. | Cell Signal | 2024 | 38336189 | PubTator, text mining | PubMed |
| Unveiling the oncogenic role of CLDN11-secreting fibroblasts in gastric cancer peritoneal metastasis through single-cell sequencing and experimental approaches. | Int Immunopharmacol | 2024 | 38335659 | PubTator, text mining | PubMed |
| MIF modulates p38/ERK phosphorylation via MKP-1 induction in sarcoidosis. | iScience | 2024 | 38299032 | PubTator, text mining | PubMed |
| Spatial transcriptomics reveals that metabolic characteristics define the tumor immunosuppression microenvironment via iCAF transformation in oral squamous cell carcinoma. | Int J Oral Sci | 2024 | 38287007 | PubTator, text mining | PubMed |
| A novel disulfidptosis-related lncRNA signature for predicting prognosis and potential targeted therapy in hepatocellular carcinoma. | Medicine (Baltimore) | 2024 | 38277541 | PubTator, text mining | PubMed |
| HTLV-1 Tax Tug-of-War: Cellular Senescence and Death or Cellular Transformation. | Pathogens | 2024 | 38276160 | PubTator, text mining | PubMed |
| Quantitative Determination of Cholesterol Hydroxylase Specificities by GC-MS/MS in Living Mammalian Cells. | Bio Protoc | 2024 | 38268974 | PubTator, text mining | PubMed |
| Atypical chemokine receptors in cancer. | Cytokine | 2024 | 38266462 | PubTator, text mining | PubMed |
| The Involvement of Cysteine-X-Cysteine Motif Chemokine Receptors in Skin Homeostasis and the Pathogenesis of Allergic Contact Dermatitis and Psoriasis. | Int J Mol Sci | 2024 | 38256077 | PubTator, text mining | PubMed |
| Integrin-associated transcriptional characteristics of circulating tumor cells in breast cancer patients. | PeerJ | 2024 | 38250718 | PubTator, text mining | PubMed |
| Cytotoxic Effect of Andrographis paniculata Associated with 2-Aminoethyl Dihydrogen Phosphate in Triple-Negative Breast Cells. | Curr Issues Mol Biol | 2024 | 38248336 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57007/papers?page=11